By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Covance Inc. 

210 Carnegie Center

Princeton  New Jersey  08540-6233  U.S.A.
Phone: 888-COVANCE Fax: 609-452-9375


Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.3 billion, global operations in more than 20 countries, and more than 8,100 employees worldwide.

Driven by a commitment to scientific, operational and service excellence, we help sponsors accomplish all of their drug development goals, including:

  • Proving early safety
  • Conducting first-in-human studies
  • Conducting proof-of-concept studies
  • Proving safety and efficacy
  • Filing for marketing approval
  • Launching and marketing a drug
  • Ensuring patient safety and access
  • Managing risk

    We focus on meeting sponsors' timelines, delivering high-quality error-free data and providing exceptional customer service to successfully advance their compounds through the drug development continuum - as safely, efficiently and cost-effectively as possible.

    Worldwide, Covance provides the following drug development services to pharmaceutical and biotechnology companies of all sizes:

  • Research Products
  • Antibody Services
  • Biomarker Services
  • Nonclinical Development Services
  • Clinical Pharmacology Services
  • Cardiac Safety Services
  • Central Laboratory Services
  • Virtual Central Laboratory Services
  • Clinical Development Services
  • Risk Management Services
  • Commercialization Services
  • Outcomes & Consulting Services

    Indianapolis – 8211 SciCor Dr / Indianapolis, IN 46214
    Greenfield - 671 South Meridian Rd/ Greenfield, IN 46140
    Madison - 3301 Kinsman Blvd./Madison, WI 53704

    Key Statistics

    Ownership: Public

    Web Site: Covance
    Employees: 8,100
    Symbol: CVD

  • Industry

    Company News
    Emulate Announces Strategic Collaboration With Covance (CVD) To Integrate Organs-on-Chips Technology In Drug Evaluation 10/20/2016 1:09:47 PM
    LabCorp (LH) Names Biopharma Vet CEO of Covance (CVD) Drug Development 9/20/2016 11:44:15 AM
    Two Former Covance (CVD) Senior Executives Join MedAvante Board Of Directors 6/22/2016 8:03:24 AM
    LabCorp (LH) Hires Jonathan Zung As Group President Of Clinical Development And Commercialization Services For Covance (CVD) Drug Development 4/11/2016 8:29:59 AM
    Covance (CVD) Announces Mobile Health Solutions To Support Use Of Mobile Technology In Clinical Trials 3/14/2016 7:48:02 AM
    NeoGenomics (NGNM.OB) Amends Strategic Alliance Agreement With Covance (CVD) Central Laboratory Services 10/29/2015 6:27:23 AM
    Covance (CVD) Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Two Years In A Row 10/19/2015 10:41:02 AM
    132 Covance (CVD) Jobs in Jeopardy 10/19/2015 6:58:01 AM
    Covance (CVD) To Open Second Current Good Manufacturing Practice (cGMP) Pharmacy In U.S. 9/22/2015 11:17:56 AM
    Covance (CVD) Announces Pioneering Agreement With Leading Pharmaceutical Company For Worldwide Portfolio-Level Clinical Trial Monitoring 8/25/2015 9:33:46 AM